Emergent Biosolutions: Credit Suisse Antibody Day (Emergent Biosolutions) - May 10, 2013 - "Preliminary results"; "Different levels of Assessment"; "Best Response at any time per investigator"; "NCI: 2 months duration, PE and CBC"; "IWCLL: same as NCI but includes CT scan and for CR 2 months duration is after completing Rx"; "4 CRs under NCI did not reach IWCLL criteria"; "2 did not have repeat scans"; "2 had nodes >1.5 cm; 1.6 cm and other 1.8 cm"
P1/2 data • Hematological Malignancies • Non-Hodgkin's Lymphoma
|